Neo Ivy Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,038
Closed -$321K 479
2025
Q3
$321K Sell
30,038
-100,098
-77% -$982K 0.08% 267
2025
Q2
$1.26M Buy
+130,136
New +$1.34M 0.4% 88
2025
Q1
Sell
-21,861
Closed -$326K 388
2024
Q4
$326K Sell
21,861
-103,793
-83% -$1.69M 0.07% 207
2024
Q3
$2.4M Buy
+125,654
New +$2.6M 0.78% 32

Other funds holding OGN

Neo Ivy Capital Management's OGN Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 30,038 shares — an estimated $321K sold.

Neo Ivy Capital Management first reported a position in OGN in Q3 2024 and held it in 4 quarters. The position peaked at $2.4M in Q3 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 30,038 Organon & Co shares in Q4 2025, an estimated $321K.
  • Neo Ivy Capital Management first reported a position in Organon & Co in Q3 2024 and held it in 4 quarters.
  • Neo Ivy Capital Management's Organon & Co position peaked at $2.4M in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.